FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid

Product#: DCP-MEMH-RN1X
$44.00
DCP-MEMH-RN1X
Availability:
Ships in 1-2 Weeks

warning For Research Use Only (RUO). Not intended for clinical, diagnostic, or therapeutic use in humans.
ISO 13485 Certified Manufacturing

FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid

Contains L-Glutamine Contains Sodium Bicarbonate Contains HEPES Contains Calcium Contains Magnesium Contains Glucose Contains Sodium Pyruvate Without Phenol Red

FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid is a Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) 1X liquid cell culture medium engineered for organ-on-a-chip (OoC), tissue-on-a-chip (ToC), and microphysiological system (MPS) applications. The validated four-pass train reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration — making it microchannel-safe from day one.

  • Quadruple-stage filtration train: 0.1 µm ×2 (Prefiltration I & II) + 0.04 µm ×2 (Final filtration I & II), reaching a 0.04 µm final cut-off
  • Low-glucose MEM base (D-Glucose 1.0 g/L) buffered with 25 mM HEPES (5958 mg/L) plus sodium bicarbonate (2200 mg/L) for dual-buffer flexibility
  • Phenol red-free formulation for fluorescence- and absorbance-sensitive assays
  • Endotoxin release specification: < 0.05 EU/mL (LAL, USP <85> BET), controlled per manufacturing batch
  • Manufactured under an ISO 13485:2016 quality management system; final packaging, testing and customization at Diagnocine Precision, Totowa, NJ
  • Prepared with Ultrapure Type 1 water (18.2 MΩ·cm)
  • Custom formulations available — pH, glucose, salts, HEPES, and nutrient composition on request
DCP-MEMH-RN1X | Sizes: 500 mL, 1000 mL |Cell Culture Media
UNSPSC: 41116155 | Commodity: Molecular biology and cell culture growth media | (UNv260801)
Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid
  • Glucose1000 mg/L (1.0 g/L)
  • L-Glutamine292 mg/L
  • Sodium Pyruvate110 mg/L
  • HEPES5958 mg/L (25 mM)
  • pH (USP <791>)7.4
  • Osmolality (USP <785>)See CoA
  • Endotoxin (USP <85>)< 0.05 EU/mL
  • Filtration0.1 µm ×2 + 0.04 µm ×2 (Quadruple-stage)
  • Storage2–8°C, protect from light
  • Shelf Life12 months from date of manufacture, unopened
ISO 13485:2016 USP <85> <785> <788> RUO
Why FluxMPS™

Engineered where standard media fails

Conventional 0.22 µm-filtered media can carry mycoplasma-sized organisms (approximately 0.2–0.3 µm), subvisible debris, and inconsistent endotoxin levels that accumulate inside microchannels — corrupting biosensor readings, stressing primary cultures, and shortening device lifetimes. FluxMPS™ is engineered to address these failure modes at the source.

filter_alt

Microchannel-safe purity

0.04 µm final filter retains particles to sub-mycoplasma size; USP <788> Method 1 (light obscuration) particulate compliance verified per lot.

target

Total metabolic control

User-defined carbon source and precise nutrient concentrations support metabolic flux experiments and Warburg-pathway research.

water_drop

Ultrapure-grade water

Prepared with Type 1 water (18.2 MΩ·cm) under strict trace-metal and total organic carbon (TOC) control.

visibility

Low background for imaging

Quadruple-stage filtration keeps particulate and debris load to a minimum, supporting cleaner backgrounds for confocal microscopy, live-cell biosensors, and TEER measurements.

science

Rich, stable nutrient profile

Micro-batch precision locks in amino acid and vitamin concentrations for lot-to-lot reproducibility in long-term perfusion studies.

tune

Customization on demand

pH, glucose, salts, HEPES, and full nutrient composition available on request. Contact support@diagnocine.com.

Purity Architecture

Quadruple-stage filtration system

FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid is processed through a validated four-pass filtration train — two paired 0.1 µm prefilter / 0.04 µm final-filter stages in series — reaching a 0.04 µm final cut-off, well beyond what single-pass 0.22 µm filtration can achieve.

  1. 1

    0.1 µm Prefiltration I

    Removes large particulates, cell debris and protein aggregates; protects the first 0.04 µm final-filter cartridge.

  2. 2

    0.04 µm Final filtration I

    First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass through a 0.22 µm membrane, including material in the 0.2–0.3 µm mycoplasma size range.

  3. 3

    0.1 µm Prefiltration II

    Second dedicated prefilter, protecting the second 0.04 µm final-filter cartridge and providing full-train redundancy.

  4. 4

    0.04 µm Final filtration II — Polish

    Ultimate polishing filter; aseptic fill and finish in a validated ISO Class 5 laminar-flow workstation.

Performance vs. conventional media

A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off — five times finer than the 0.22 µm membranes used for conventional sterile filtration — with USP <788> Method 1 particulate compliance verified on every lot.

0.04
µm final filter pore size — sub-mycoplasma polishing
4
Sequential filtration passes (0.1 µm ×2 + 0.04 µm ×2)
Sterility assurance: Every lot undergoes 14-day USP <71> sterility testing. Mycoplasma organisms are typically 0.2–0.3 µm in diameter; the 0.1 µm and 0.04 µm filtration stages above provide mycoplasma-retentive filtration as a risk-mitigation measure. This is not a substitute for a USP <63> mycoplasma detection assay, which is not performed per lot.
Grade: This product is Microfluidics Suitable, filtered to a 0.04 µm final cut-off. It is not an MPS Grade product — that designation is reserved for the 0.01 µm ultra nano-filtered line, which adds 0.02 µm and 0.01 µm stages after the 0.04 µm polish. For applications requiring the 0.01 µm cut-off, contact support@diagnocine.com.
FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid (DCP-MEMH-RN1X) Quadruple-stage filtration system: 0.1 μm Prefiltration I, 0.04 μm Final filtration I, 0.1 μm Prefiltration II, 0.04 μm Final filtration II Polish for organ-on-a-chip and microfluidic applications by Diagnocine
Figure 1. FluxMPS™ Quadruple-stage filtration architecture (0.1 µm ×2 + 0.04 µm ×2).
© Diagnocine® — DCP-MEMH-RN1X
Applications

Designed for next-generation cell culture platforms

FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid is validated for organ-on-a-chip, metabolic research, live-cell imaging, and primary cell models where particulate contamination and endotoxin variation are unacceptable.

Automated Bioreactors & Robotics

Next-Generation System Uptime

An optional 0.01 µm (10 nm) MPS Grade variant is available for automated bioreactor and robotic perfusion systems requiring the ultimate particulate exclusion.

  • Total Particulate Exclusion: 10 nm filtration for nanoscale valve and sensor protection
  • Valve & Sensor Protection: reduces risk of particulate-induced blockage in precision fluidic systems
  • Extended Perfusion Stability: supports flow-rate consistency across multi-week automated runs

Inquiry Required: Contact support@diagnocine.com to request the 0.01 µm MPS Grade variant.

Microfluidics

Micro Physiological System (MPS) & Chip

Quadruple-stage filtration reduces the risk of microchannel clogging and helps maintain laminar flow integrity in microfluidic chip formats.

OoCToCBoCLoCMPS
Cancer Biology

Warburg Effect & Metabolic Research

Defined low-glucose carbon source and a low-endotoxin background support precise metabolic flux analysis in cancer cell models.

MCF-7MDA-MB-231HeLaHT-1080
Stem Cell Biology

iPSC-Derived Models

Ultra-filtered formulation supports sensitive iPSC differentiation protocols where endotoxin variability can cause off-target effects.

iPSC-NeuronsiPSC-CMiPSC-Hep
Vascular Biology

Endothelial & Primary Cells

Microchannel-safe purity supports endothelial barrier integrity and TEER-based assays.

HUVECsBHK-21Primary fibroblasts
Metabolomics

Metabolic Flux Analysis

Defined base composition supports isotope tracing (13C) and NMR-based metabolic flux workflows. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.

13C tracingNMR metabolomics
Live-Cell Imaging

Microscopy & Optical Sensing

Quadruple-stage filtration keeps particulate load low, supporting confocal imaging, live-cell biosensor assays, and TEER measurements.

ConfocalBiosensorsTEER
Technical Specifications

Lot-release quality parameters

Every production batch of FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid undergoes the complete quality-release battery below before shipment. Available pack sizes: 500 mL, 1000 mL.

Physical & Chemical Parameters
Parameter Specification
Formulation L-Glutamine, Sodium Bicarbonate, HEPES, Calcium, Magnesium, Glucose, Sodium Pyruvate present; Phenol Red not added
Appearance Pale yellow-colored, clear solution
pH USP <791> 7.4
Osmolality USP <785> See CoA
Glucose 1000 mg/L (1.0 g/L)
L-Glutamine 292 mg/L
Sodium Pyruvate 110 mg/L
Phenol Red Not added
Sterility, Purity & Safety Parameters
Parameter Specification
Endotoxin USP <85> BET < 0.05 EU/mL
Sterility USP <71> No growth after 14 days
Mycoplasma 0.1 µm & 0.04 µm mycoplasma-retentive filtration (not tested per lot)
Particulate ≥10 µm USP <788> Method 1 Compliant
Particulate ≥25 µm USP <788> Method 1 Compliant
Water purity Ultrapure Type 1, 18.2 MΩ·cm
Manufacturing std. ISO 13485 ISO 13485:2016
Fill environment ISO Class 5 (Class 100)
Storage, Handling & Logistics
Parameter Specification
Storage temperature 2–8°C, protected from light
Freeze-thaw Not recommended
Shelf life 12 months from date of manufacture, unopened
Shipping condition Cold pack
CO₂ requirement HEPES-buffered; reduced CO₂ dependence (~5% CO₂ compatible; validate per cell line)
Raw Materials & Regulatory Traceability
Parameter Specification
Raw material grade Cell culture / reagent grade
Traceability Full lot documentation, CoA available
Manufacturing QMS ISO 13485:2016 certified
UNSPSC 41116155 — Molecular biology and cell culture growth media (UNv260801)
Regulatory alignment 21 CFR Part 820 (QMSR) aligned
Production method Micro-batch precision manufacturing
Intended use For Research Use Only (RUO)
Formulation

Full composition (mg/L)

Complete formulation with CAS numbers, reproduced from manufacturer specification. Total: 30 components. Custom compositions available on request.

Component CAS Number mg/L
INORGANIC SALTS
Calcium chloride dihydrate 10035-04-8 265.000
Magnesium sulfate anhydrous 7487-88-9 97.720
Potassium chloride 7447-40-7 400.000
Sodium bicarbonate 144-55-8 2200.000
Sodium chloride 7647-14-5 6800.00
Sodium phosphate dibasic anhydrous 7558-79-4 122.000
Component CAS Number mg/L
AMINO ACIDS
L-Arginine hydrochloride 1119-34-2 126.000
L-Cystine dihydrochloride 30189-89-0 31.300
L-Glutamine 56-85-9 292.000
L-Histidine hydrochloride monohydrate 5934-29-2 42.000
L-Isoleucine 73-32-5 52.000
L-Leucine 61-90-5 52.000
L-Lysine hydrochloride 657-27-2 72.500
L-Methionine 63-68-3 15.000
L-Phenylalanine 63-91-2 32.000
L-Threonine 72-19-5 48.000
L-Tryptophan 73-22-3 10.000
L-Tyrosine disodium salt 69847-45-6 51.900
L-Valine 72-18-4 46.000
Component CAS Number mg/L
VITAMINS
Choline chloride 67-48-1 1.000
D-Ca-Pantothenate 137-08-6 1.000
Folic acid 59-30-3 1.000
Niacinamide 98-92-0 1.000
Pyridoxine hydrochloride 58-56-0 1.000
Riboflavin 83-88-5 0.100
Thiamine hydrochloride 67-03-8 1.000
OTHERS
D-Glucose 50-99-7 1000.000
HEPES 7365-45-9 5958.000
Sodium Pyruvate 113-24-6 110.000
i-Inositol 87-89-8 2.000
Customization: pH, glucose, salt balance, HEPES, and full nutrient profile available on request. Contact support@diagnocine.com.
Quality Assurance

ISO 13485:2016 manufacturing & compliance

Manufactured under ISO 13485:2016 QMS with final packaging, testing, and customization at Diagnocine Precision in Totowa, New Jersey, USA.

verified

ISO 13485:2016 QMS

Full quality management system certification covering manufacturing, testing, and release for FluxMPS™ media.

water_drop

Ultrapure Type 1 Water

All media prepared with 18.2 MΩ·cm resistivity water under strict trace-metal and TOC control.

biotech

ISO Class 5 Fill & Finish

Aseptic filling performed in validated ISO Class 5 laminar-flow workstations.

assignment

Micro-Batch Precision

Small-batch manufacturing supports lot-to-lot nutrient consistency for reproducible perfusion studies.

Endotoxin — USP <85> BET

LAL assay per batch. Release specification: < 0.05 EU/mL.

Particulate — USP <788> Method 1

Light obscuration particle count confirms ≥10 µm and ≥25 µm compliance per lot.

Osmolality — USP <785>

Freezing-point osmometry per USP <785>. Result: see CoA.

Documentation — CoA & Full Lot Records

Certificate of Analysis with full QC panel, traceability, and release signatures for every lot.

Batch-level quality control. Endotoxin is controlled per manufacturing batch rather than per unit. Every batch is tested before release and must meet the release specification:
  • Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
  • pH, osmolality, conductivity, appearance and clarity
  • Sterility
A Certificate of Analysis is available on request.
Certificate of Analysis: Request via support@diagnocine.com with your lot number.
Product Comparison

How DCP-MEMH-RN1X (FluxMPS™) compares

Side-by-side comparison against conventional 0.22 µm-filtered alternatives of the same base formulation.

Parameter DCP-MEMH-RN1X (FluxMPS™) Conventional MEM (0.22 µm) Standard MEM alternative
Grade Microfluidics Suitable Standard filtered Standard filtered
Base Formulation Low Glucose & 25mM HEPES w/o Phenol Red MEM MEM Standard MEM Equivalent
Final filtration pore size 0.04 µm 0.22 µm 0.22 µm
Number of filtration stages 4 stages 1 stage 1–2 stages
Mycoplasma barrier filtration check_circle cancel cancel
Endotoxin (release specification) < 0.05 EU/mL Corning classical liquid media — < 0.25 EU/mL
Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL
Gibco classical DMEM — Not specified (recorded per lot)
USP particulate compliance check_circle USP <788> Method 1 cancel cancel
Water quality Ultrapure Type 1 (18.2 MΩ) Purified water Purified water
Manufacturing QMS ISO 13485:2016 Variable Variable
Microfluidic channel compatibility check_circle Validated cancel Risk of clogging cancel Risk of clogging
Custom formulation check_circle On request cancel Limited

Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".

FAQ

Frequently asked questions

Common questions about FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid and Microfluidics Suitable cell culture media.

Yes. DCP-MEMH-RN1X is Microfluidics Suitable, processed through our quadruple-stage filtration train (0.1 µm ×2 + 0.04 µm ×2) that reaches a 0.04 µm final cut-off, reducing the particulate and microaggregate load that can accumulate in microfluidic channels and OoC/MPS devices.
Standard 0.22 µm filtration does not retain mycoplasma-sized organisms (approximately 0.2–0.3 µm) or the sub-micron particulates that accumulate in microchannels. FluxMPS™ uses four sequential passes (0.1 µm ×2 + 0.04 µm ×2) reaching a 0.04 µm final cut-off — five times finer than a 0.22 µm membrane — with USP <788> Method 1 particulate compliance verified on every lot.
This formulation contains 1000 mg/L (1.0 g/L) D-Glucose, a low-glucose MEM base. For cell types requiring higher glucose, contact support@diagnocine.com for a custom concentration, or supplement directly with sterile-filtered D-glucose stock before use.
This formulation is buffered with both 25 mM HEPES and sodium bicarbonate (2200 mg/L). It is compatible with standard 5% CO₂ incubation and offers reduced CO₂ dependence for short bench-top or microfluidic perfusion work outside the incubator; validate against your specific cell line.
Yes. FluxMPS™ Minimum Essential Medium (MEM), Low Glucose & 25mM HEPES w/o Phenol Red: 1X Liquid can be supplemented with FBS (5–20%), growth factors, antibiotics, or other additives per standard practice. Pre-filter serum and protein-containing additions through a 0.2 µm low-protein-binding PES or PVDF filter before addition; do not use a 0.04 µm filter for supplements, as it will strip serum proteins and lipoproteins. Add supplements immediately before use.
Endotoxin is controlled per manufacturing batch. Every batch is tested by LAL assay (USP <85> Bacterial Endotoxins Test, assay sensitivity 0.005 EU/mL) before release and must meet the release specification of < 0.05 EU/mL. A Certificate of Analysis is available on request.
Yes. A batch-specific CoA is available for every shipment and includes appearance, pH (USP <791>), osmolality (USP <785>), endotoxin (USP <85> BET), sterility (USP <71>), particulate matter (USP <788> Method 1), raw material traceability, manufacturing date, and authorized release signatures. Request via support@diagnocine.com.
Scientific References

Supporting literature

Peer-reviewed publications supporting Microfluidics Suitable ultra-filtered media and microfluidic cell culture applications.

  1. Huh D et al. (2010). Reconstituting organ-level lung functions on a chip. Science, 328(5986), 1662–1668. doi:10.1126/science.1188302
  2. Bhatia SN & Ingber DE (2014). Microfluidic organs-on-chips. Nature Biotechnology, 32(8), 760–772. doi:10.1038/nbt.2989
  3. Eagle H (1959). Amino acid metabolism in mammalian cell cultures. Science, 130(3373), 432–437. doi:10.1126/science.130.3373.432
  4. Bhattacharya S et al. (2018). Challenges in maintaining cell viability during microfluidic experiments. Electrophoresis, 39(7), 997–1006. doi:10.1002/elps.201700375
  5. Zhang YS et al. (2017). Multisensor-integrated organs-on-chips platform for automated in situ monitoring. PNAS, 114(12), E2293–E2302. doi:10.1073/pnas.1612906114
  6. Vernetti L et al. (2017). Functional coupling of human microphysiology systems. Scientific Reports, 7, 42296. doi:10.1038/srep42296
  7. Esch EW et al. (2015). Organs-on-chips at the frontiers of drug discovery. Nature Reviews Drug Discovery, 14(4), 248–260. doi:10.1038/nrd4539
  8. Zheng F et al. (2021). Organ-on-a-chip systems: microengineering to biomimic living systems. Small, 17(7), 2004175. doi:10.1002/smll.202004175

Satisfaction
Quality Rating
Value Rating
Style Rating
X